| Brand Name: |
Fungotek |
| Generic Name: |
Terbinafine Hydrocholoride |
| Form: |
Tablets |
| Manufacturer: |
FDC Limited |
What is Fungotek?
Fungotek containing the active ingredient terbinafine hydrocholoride is considered an antifungal type of medication. The medication works by stopping the growth and kill fungus causing infections. The tablets are used to treat fingernail and toenail infections as they are hard to treat with topical medication.
How is Fungotek used?
Fungotek is usually taken orally once per day or as directed by a doctor. The tablets can be taken with or without food but should be taken with a glass of water. Contact a doctor for the correct dosage and length of treatment as it will depend on the patient’s condition and their response to the therapy. Do not discontinue the medication without finishing the course of the prescribed medication as abruptly stopping the medication may cause the infection to return.
Adverse effects
Patients using Fungotek may cause unwanted side effects such as:
- Diarrhea
- Upset stomach
- Headaches
- Change or loss in taste
- Vomiting
- Change in appetite
- New signs of infection
- Jaundice
Contact a doctor immediately should side effects persist or worsen.
Warnings
Immediately proceed to your nearest emergency department if you suffer an allergic reaction. Symptoms usually associated with such a reaction include difficulty breathing or swallowing, chest tightness, swelling, skin rashes, and hives.
Fungotek is not always suitable for all patients. Always consult your health care provider prior to using this medication if you are pregnant, breastfeeding, trying to conceive, using any other medication (prescription or non-prescription), using any herbal products or supplements, or if you have any allergies or other health problems.
The correct dosage and prescription commonly depend on the patient and the condition being treated. Do not adjust your dosage without the approval of your health care provider. This product is only for use as prescribed and instructed. |
